$670 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 65 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AGN | Exit | ALLERGAN PLC | $0 | – | -4,800 | -100.0% | -0.14% | – |
| SBPH | Exit | SPRING BK PHARMACE | $0 | – | -276,656 | -100.0% | -0.16% | – |
| URGN | Exit | UROGEN PHARMA LTD | $0 | – | -65,063 | -100.0% | -0.27% | – |
| SVRA | Exit | SAVARA INC | $0 | – | -710,310 | -100.0% | -0.32% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -147,211 | -100.0% | -0.51% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -1,240,865 | -100.0% | -0.62% | – |
| FTSV | Exit | FORTY SEVEN INC | $0 | – | -814,414 | -100.0% | -0.90% | – |
| OBSV | Exit | OBSEVA SA | $0 | – | -643,151 | -100.0% | -0.92% | – |
| PFE | Exit | PFIZER INC | $0 | – | -183,528 | -100.0% | -1.14% | – |
| XLRN | Exit | ACCELERON PHARMA | $0 | – | -227,596 | -100.0% | -1.55% | – |
| LJPC | Exit | LA JOLLA PHARMACLS | $0 | – | -1,158,271 | -100.0% | -1.76% | – |
| RARX | Exit | RA PHARMACEUTICALS | $0 | – | -451,247 | -100.0% | -1.84% | – |
| NVS | Exit | NOVARTIS AGsponsored adr | $0 | – | -147,846 | -100.0% | -2.22% | – |
| SWAV | Exit | SHOCKWAVE MEDICAL | $0 | – | -573,434 | -100.0% | -2.96% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -1,063,872 | -100.0% | -3.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.